Lyell Immunopharma, Inc. LYEL
16.15 USD +0.73 (+4.74%)
Nov 10, 2026, 11:14 AM EST
14.92 Day range 16.51
7.20 52-week range 45.00
- YTD
- -47.53%
- 1 year
- -8.65%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 36.00K | 61.00K | 130.00K | 84.68M | 10.65M | |
| 36.00K | 61.00K | 130.00K | 84.68M | 10.65M | |
| 36.00K | 61.00K | 130.00K | 84.68M | 10.65M | |
| 269.44M | 358.82M | 247.14M | 271.74M | 225.43M | |
| 158.68M | 171.60M | 182.94M | 159.19M | 138.69M | |
| 45.13M | 52.04M | 66.98M | 117.31M | 89.06M | |
| -269.40M | -358.75M | -247.01M | -187.06M | -214.78M | |
| -274.45M | -342.99M | -234.63M | -183.12M | -250.22M | |
| -274.45M | -342.99M | -234.63M | -183.12M | -250.22M | |
| -274.45M | -342.99M | -234.63M | -183.12M | -250.22M | |
| -274.45M | -342.99M | -234.63M | -183.12M | -250.22M | |
| -16.06 | -26.23 | -18.70 | -14.80 | -36.80 | |
| -16.06 | -26.23 | -18.70 | -14.80 | -36.80 | |
| -16.06 | -26.23 | -18.70 | -14.80 | -36.80 | |
| -274.45M | -342.99M | -234.63M | -183.12M | -250.22M | |
| -274.45M | -342.99M | -234.63M | -183.12M | -250.22M | |
| 17.09M | 13.07M | 12.55M | 12.35M | 6.80M | |
| 17.09M | 13.07M | 12.55M | 12.35M | 6.80M |